Calcineurin inhibition in hypertrophy: Back from the dead!

Circulation

Volumn 104, Issue 1, 2001, Pages 9-11

  Dorn II, Gerald W ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Calcineurin; Cardiomyopathy; Editorials; Hypertrophy; Inhibitors

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; TACROLIMUS;

CELLULAR IMMUNITY; EDITORIAL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035800091     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.1.9     Document Type: Editorial

References (10)

1. The mechanism of hypertrophy and wear of the myocardium
2. Gq signaling in cardiac adaptation and maladaptation
3. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
4. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
5. Calcineurin and beyond: Cardiac hypertrophic signaling
6. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
7. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy
8. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
9. Myocyte-enriched calcineurin-interacting protein, MCIP1 inhibits cardiac hypertrophy in vivo
10. (2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy